JFG
JSPR icon

Jefferies Financial Group’s Jasper Therapeutics JSPR Stock Holding History

Jefferies Financial Group’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,250
Closed -$668K – 1816
2024
Q4 		$668K Buy
+31,250
New +$651K ﹤0.01% 1021
2023
Q3 		– Sell
-48,988
Closed -$671K – 1789
2023
Q2 		$671K Buy
+48,988
New +$728K 0.01% 1072

Other funds holding JSPR

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Jefferies Financial Group's JSPR Position: Q1 2025 in Review

Jefferies Financial Group sold out of Jasper Therapeutics (JSPR) in Q1 2025, closing a stake of 31,250 shares — an estimated $668K sold.

Jefferies Financial Group first reported a position in JSPR in Q2 2023 and held it in 2 quarters. The position peaked at $671K in Q2 2023. 68 funds tracked by Wall St. Rank hold JSPR as of Q1 2025.

  • Jefferies Financial Group reported no remaining Jasper Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 31,250 Jasper Therapeutics shares in Q1 2025, an estimated $668K.
  • Jefferies Financial Group first reported a position in Jasper Therapeutics in Q2 2023 and held it in 2 quarters.
  • Jefferies Financial Group's Jasper Therapeutics position peaked at $671K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.